EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Using energy to go downhill—a genoprotective role for ATPase activity in DNA topoisomerase II

Afif F Bandak, Tim R Blower iD, Karin C Nitiss iD, Viraj Shah, John L Nitiss iD, James M Berger iD

Nucleic Acids Research · 2024

DOI: 10.1093/nar/gkad1157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Afif F Bandak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins University School of Medicine, Department of Biophysics and Biophysical Chemistry, Baltimore, MD 21205, USA. Hauptthemen laut MEDLINE: DNA, DNA Topoisomerases, Type II. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NINDS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type II topoisomerases effect topological changes in DNA by cutting a single duplex, passing a second duplex through the break, and resealing the broken strand in an ATP-coupled reaction cycle. Curiously, most type II topoisomerases (topos II, IV and VI) catalyze DNA transformations that are energetically favorable, such as the removal of superhelical strain; why ATP is required for such reactions is unknown. Here, using human topoisomerase IIβ (hTOP2β) as a model, we show that the ATPase domains of the enzyme are not required for DNA strand passage, but that their loss elevates the enzyme's propensity for DNA damage. The unstructured C-terminal domains (CTDs) of hTOP2β strongly potentiate strand passage activity in ATPase-less enzymes, as do cleavage-prone mutations that confer hypersensitivity to the chemotherapeutic agent etoposide. The presence of either the CTD or the mutations lead ATPase-less enzymes to promote even greater levels of DNA cleavage in vitro, as well as in vivo. By contrast, aberrant cleavage phenotypes of these topo II variants is significantly repressed when the ATPase domains are present. Our findings are consistent with the proposal that type II topoisomerases acquired ATPase function to maintain high levels of catalytic activity while minimizing inappropriate DNA damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNADNA Topoisomerases, Type IIHumansAdenosine TriphosphatasesAdenosine TriphosphateEtoposideDNA Damage

Substanzen

Adenosine TriphosphatasesAdenosine TriphosphateDNADNA Topoisomerases, Type IIEtoposide

Autor:innen und Institutionen

  • Johns Hopkins University School of Medicine, Department of Biophysics and Biophysical Chemistry, Baltimore, MD 21205, USA.
  • Pharmaceutical Sciences Department, University of Illinois College of Pharmacy, 1601 Parkview Avenue, Rockford, IL 61107, USA.
  • Biomedical Sciences Department, University of Illinois College of Medicine, 1601 Parkview Avenue, Rockford, IL 61107, USA.

ORCID-Profile: Tim R Blower, Karin C Nitiss, John L Nitiss, James M Berger

Förderung

  • NCI NIH HHS
  • NINDS NIH HHS
  • NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • EMBO

Zitieren

APA

Bandak, A. F., Blower, T. R., Nitiss, K. C., Shah, V., Nitiss, J. L., & Berger, J. M. (2024). Using energy to go downhill—a genoprotective role for ATPase activity in DNA topoisomerase II. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad1157

Vancouver

Bandak AF, Blower TR, Nitiss KC, Shah V, Nitiss JL, Berger JM. Using energy to go downhill—a genoprotective role for ATPase activity in DNA topoisomerase II. Nucleic Acids Research. 2024. doi:10.1093/nar/gkad1157

BibTeX
@article{Bandak2024,
  author = {Bandak, Afif F and Blower, Tim R and Nitiss, Karin C and Shah, Viraj and Nitiss, John L and Berger, James M},
  title = {Using energy to go downhill—a genoprotective role for ATPase activity in DNA topoisomerase II},
  journal = {Nucleic Acids Research},
  year = {2024},
  doi = {10.1093/nar/gkad1157}
}
Kostenlos starten →